EU healthcare procurement reform should prioritize quality over price-only bidding, not just buying European
Europe’s healthcare resilience depends less on buying European and more on buying better. Price-only procurement undermines innovation, outcomes and competitiveness. Revising EU procurement rules to…
Read the full articleYou might also wanna read
Understanding Heterogeneous Drug Procurement Behaviour of Healthcare Institutions Under Pooled Procurement: Evidence From China
Background While the overall impact of pooled drug procurement on drug procurement has been evaluated, little is known about how healthcare
Harmonising access and reinventing the procurement of innovative medicines in Europe
Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing externa
Stakeholder Perspectives on the Structural Causes of Drug Shortages in Korea: A Mixed-Methods Study
Background Drug shortages are a persistent global challenge. In South Korea, shortages occur within a distinct context characterized by high
Competing for inputs: how the European Union can improve critical raw materials supply security
EU critical raw materials projects fall short of self-sufficiency targets, making trade deals and targeted investment central to supply secu
UK tumbles down global rankings for pharma investment and research
A new Pharmaceutical Competitiveness Framework reveals that the UK is losing the race for investment in R&D, clinical trial delivery, and fo
Preparing Deal Teams for the New EU Pharmaceutical Legislation
The European Union’s new pharmaceutical legislation, the most significant reform of the EU medicines framework in over two decades, will hav
Comments
Sign in to join the conversation.
No comments yet. Be the first.